Your browser doesn't support javascript.
loading
Use of recombinant factor VII for massive posrtpartum haemhorrage: Case serie and review of literature
JPMA-Journal of Pakistan Medical Association. 2005; 55 (11): 512-515
in English | IMEMR | ID: emr-72633
ABSTRACT
Recombinant activated factor VII is indicated mainly for the treatment of patients with haemophilia inhibitors. It has also been found successful in the treatment of platelet disorder Glanzmann's thrombasthenia. Recently, its use in trauma patients and in patients with intracereberal haemorrhage has become well established. We present three cases of massive post partum haemorrhage treated with rFVIIa, following caesarean section. The response of these three patients is discussed along with review of literature
Subject(s)
Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Factor VIIa / Review Limits: Female / Humans Language: English Journal: J. Pak. Med. Assoc. Year: 2005

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Factor VIIa / Review Limits: Female / Humans Language: English Journal: J. Pak. Med. Assoc. Year: 2005